Autophagy signaling mediated by non-coding RNAs: Impact on breast cancer progression and treatment

Lei Yan1, Zhuo Quan1, Tiantian Sun2

  • 1Clinical Experimental Centre, Xi'an International Medical Center Hospital, No.777 Xitai Road, High-tech Zone, Xi'an, Shaanxi Province, 710100, China; Xi'an Engineering Technology Research Center for Cardiovascular Active Peptide, Xi'an, Shaanxi, 710100, China.

PubMed

Insights

Non-coding RNAs (ncRNAs) regulate autophagy, a cellular process crucial in breast cancer progression and treatment resistance. Understanding these interactions may lead to novel therapeutic strategies for breast cancer.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Autophagy is a cellular degradation process implicated in breast cancer progression and treatment resistance.
  • Non-coding RNAs (ncRNAs) are key regulators of cellular processes, including autophagy.
  • ncRNAs influence autophagy by targeting critical components like the ULK1 complex, Beclin1, and ATGs.

Purpose of the Study:

  • To review the regulatory roles of ncRNAs, especially microRNAs (miRNAs), in modulating autophagy pathways in human breast cancer.
  • To explore the potential of exploiting the autophagy-ncRNA axis for improved breast cancer treatment strategies.

Main Methods:

  • Literature review of recent research on ncRNAs and autophagy in breast cancer.
  • Analysis of the interactions between different ncRNA subtypes (miRNAs, lncRNAs, circRNAs) and autophagy pathways.
  • Investigation of the impact of these interactions on breast cancer progression and therapeutic response.

Main Results:

  • ncRNAs, including miRNAs, lncRNAs, and circRNAs, significantly regulate autophagy in breast cancer.
  • These ncRNAs can either suppress or activate autophagy, influencing cancer cell behavior and treatment sensitivity.
  • The interplay between ncRNAs and autophagy presents potential therapeutic targets for breast cancer.

Conclusions:

  • ncRNAs are critical regulators of autophagy in breast cancer, impacting disease progression and treatment outcomes.
  • Targeting the autophagy-ncRNA axis offers a promising avenue for developing novel therapeutic strategies to enhance treatment sensitivity in breast cancer.
  • Further research is needed to identify specific miRNAs as biomarkers and elucidate their precise roles in breast cancer through autophagy modulation.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.3K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.0K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K